{"id":271209,"date":"2026-06-10T03:15:11","date_gmt":"2026-06-10T03:15:11","guid":{"rendered":"https:\/\/www.europesays.com\/se\/271209\/"},"modified":"2026-06-10T03:15:11","modified_gmt":"2026-06-10T03:15:11","slug":"tablettlakemedel-daraoxanrasib-forlanger-livet-vid-bukspottkortelcancer","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/271209\/","title":{"rendered":"Tablettl\u00e4kemedel daraoxanrasib f\u00f6rl\u00e4nger livet vid bukspottk\u00f6rtelcancer"},"content":{"rendered":"<p>Publicerad 10 jun 2026 kl 05.00<\/p>\n<p>PremiumBukspottk\u00f6rtelcancer \u00e4r en av de mest d\u00f6dliga cancerformerna.\u00a0<\/p>\n<p>Nu visar en ny studie:<\/p>\n<p>Ett tablettl\u00e4kemedel h\u00e4mmar det protein som \u00e4r drivande i tum\u00f6rutvecklingen i 90 procent av fallen \u2013 och g\u00f6r att de drabbade \u00f6verlever i genomsnitt dubbelt s\u00e5 l\u00e4nge.<\/p>\n<p>\u2013 Det h\u00e4r \u00e4r v\u00e4ldigt unikt, s\u00e4ger \u00f6verl\u00e4kare Daniel \u00d6hlund.<\/p>\n<p><a href=\"https:\/\/www.expressen.se\/premium\/halsa\/\" rel=\"nofollow noopener\" target=\"_blank\">H\u00e4r hittar du mer om medicin, h\u00e4lsa och forskning!<\/a><\/p>\n<p><img   alt=\"\"\/><\/p>\n<p>En ny studie visar att ett tablettl\u00e4kemedel h\u00e4mmar det protein som \u00e4r drivande i tum\u00f6rutvecklingen hos 90 procent av fallen med bukspottk\u00f6rtelcancer.<\/p>\n<p>Foto: Rabizo Anatolii \/ Shutterstock<\/p>\n<p>\u00d6ppna bild i helsk\u00e4rm<\/p>\n","protected":false},"excerpt":{"rendered":"Publicerad 10 jun 2026 kl 05.00 PremiumBukspottk\u00f6rtelcancer \u00e4r en av de mest d\u00f6dliga cancerformerna.\u00a0 Nu visar en ny&hellip;\n","protected":false},"author":2,"featured_media":271210,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[69],"tags":[994,113,112,212,5022,5744,4649,103,34,3412,31,33,32,30,2231,6622,4181],"class_list":["post-271209","post","type-post","status-publish","format-standard","has-post-thumbnail","category-halsa","tag-function-premium-halsa","tag-halsa","tag-health","tag-location-sverige","tag-organization-cancerfonden","tag-organization-lakemedelsverket","tag-organization-socialstyrelsen","tag-premium","tag-se","tag-sections-halsa","tag-svenska","tag-sverige","tag-sweden","tag-swedish","tag-topic-cancer","tag-topic-forskning","tag-topic-lakemedel"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/116723641627279045","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/271209","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=271209"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/271209\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/271210"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=271209"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=271209"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=271209"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}